On April 27th, Huakang Medical (301235), an A-share listed company, released its first-quarter results report in 2024. Of which, the net loss is 3207.Crashbandicoot ™170,000 yuan, an increase of 85.28% over the same period last year.
According to the comprehensive operation and follow-up analysis of more than 1200 financial indicators of its financial data in the current period and the past five years by the financial diagnosis model of flush (300033), the overall financial situation of Huakang Medical in the past five years is OK. Specifically, the operating ability, debt-paying ability is general, growth ability, profitability is good.
The net loss was 32.0717 million yuan, an increase of 85.28% over the same period last year.
In terms of revenue and profit, the company achieved total operating income of 230 million yuan during the reporting period, down 4.37% from the same period last year, with a net loss of 32.0717 million yuan, an increase of 85.28% over the same period last year, and basic earnings per share of-0.30 yuan.
In terms of assets, during the reporting period, the total assets at the end of the period were 2.801 billion yuan and the accounts receivable were 1.312 billion yuan.Crashbandicoot ™In terms of cash flow, the net cash flow generated by business activities is-150 million yuan, and the cash received from the sale of goods and services is 267 million yuan.
There are two financial highlights.
According to the relevant financial information released by Huakang Medical, there are two financial bright spots in the company, as follows:
The average year-on-year growth rate of revenue is 26.99%, which is excellent in the industry. The average turnover rate of total operating assets is 0.62 (times / year), and the company has high operational efficiency.There are two financial risks
According to the relevant financial information published by Huakang Medical, the company has two financial risks, as follows:
The average cash content of income and net profit is-86.97%, and the company's cash flow is poor. The average cash-to-cash ratio of main business is 89.32%, and the company's cash flow is very weak.Overall, Huakang Medical's overall financial situation is OK, with a current total score of 2.21, ranking low among 52 companies in its medical service industry. Specifically, the operating ability, debt-paying ability is general, growth ability, profitability is good.
The scores of the indicators are as follows:
Index type previous period score ranking evaluation growth ability 4.343.7514 strong profitability 2.363.1720 good asset quality 2.172.6026 operational ability 3.111.7335 General solvency 3.211.3539 General cash flow 0.190.1052 weaker total score 2.482.2132On the large model of financial diagnosis of flush
Flush (300033) Financial diagnosis model calculates the company's financial scores, highlights and risks based on the company's latest and previous financial data and industry conditions, reflecting the company's disclosed financial position, but not a forecast of the future financial position. The financial score range is 0-5. The higher the score, the better the financial situation and the greater the value of the medium-and long-term investment. In the financial highlights and risk reviews, the five-year average of the indicators related to the "average" keyword, and the latest reporting period data without the "average" keyword. All the above information is based on artificial intelligence algorithm, for reference only, does not represent flush financial point of view, investors operate accordingly, at their own risk.
Learn more about the company's stock diagnostic information >
(: congratulations
